A blood test for belly lining scarring in peritoneal dialysis
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a protein called DKK3 in the fluid that drains from your belly during peritoneal dialysis. The goal is to see if this protein can help predict early scarring (fibrosis) of the belly lining, so doctors can monitor and treat problems sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have end-stage kidney disease and have decided to start peritoneal dialysis (dialysis using the lining of your belly).
- Your dialysis catheter will be placed at Saarland University Medical Center in Germany.
- You must be able to give your consent and be willing to sign a consent form at least 24 hours before the study begins.
- You do not have an active cancer (except a common skin cancer called basal cell carcinoma).
- You do not have an active infection in your belly (peritonitis) at the time of joining.
- Your doctor expects you to live longer than 12 months.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines fluid from your dialysis to find early warning signs of scarring in the abdominal lining (peritoneal fibrosis). The goal is to help doctors detect and manage this condition better for people on peritoneal dialysis.
This study is testing a new computer tool that helps doctors see how well peritoneal dialysis (a type of kidney treatment done at home) removes waste from your body. It may help make your dialysis more effective.
This study tests whether using a continuous glucose monitor (a small sensor that checks blood sugar levels throughout the day) can help improve diabetes control in people who are on peritoneal dialysis (a type of kidney dialysis done at home). It aims to see if this technology leads to better health outcomes.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
This study tests a simple dye test to see if fluid leaking from the chest into the belly can be detected. It is for people who are already having fluid removed from around their lungs, and the test uses a small extra sample of that fluid.
This study tests a new way to diagnose acute kidney injury (sudden kidney damage) early in intensive care patients. It may help doctors catch kidney problems sooner and improve care.
Hear when a new Peritoneal Dialysis (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.